FAS and autoimmune disease: Loss of function or dominant-negative mutations in Fas/FasL are associated with autoimmune disease [28, 91–98] and Fas overexpression facilitated tumorigenesis in vivo in a non-cell autonomous manner by promoting MDSC and Treg cell recruitment [99].